ORAL PHARMACEUTICAL DOSAGE FORMS OF BUDESONIDE
The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease. |
---|---|
Bibliography: | Application Number: US201715626426 |